Mitul Gandhi, MD

Virginia Cancer Specialists' Physicians

Mitul Gandhi, MD Headshot

I am mindful of how life altering a diagnosis of cancer can be, not just for the patient, but all the loved ones in their life as well. Patients and families rightly deserve, and will always get the very best of us in intelligence and compassion, along with access to state of the art treatment which is continually improving long-term outcomes.

Work and Credentials:

Primary Location

Gainesville Office

Other Locations

Fauquier Office
Fairfax Office


Medical Oncologist

Board Certification

Medical Oncology, Hematology, and Internal Medicine


Northwestern University Feinberg School of Medicine, Medical Oncology and Hematology


University of Michigan Health System


University of Michigan Health System

Medical School

Rutgers Robert Wood Johnson Medical School


Rutgers University

Special Interests

Malignant hematology (leukemia, lymphoma, myeloma), lung cancer, breast cancer & Clinical Trials

Physician Bio

Mitul Gandhi, M.D. attended Rutgers University where he graduated Magna Cum Laude with a Bachelor of Arts in Molecular Biology and Biochemistry. He earned his medical degree from Rutgers Robert Wood Johnson Medical School where he received the Robert Wood Johnson Foundation Research Award among other honors. Dr. Gandhi then completed his residency and internship in Internal Medicine at University of Michigan Health System.

Dr. Gandhi joins Virginia Cancer Specialists after serving as Chief Fellow in the Medical Oncology and Hematology Fellowship program at Northwestern University Feinberg School of Medicine. During his time at Northwestern, Dr. Gandhi actively participated in clinical research, with a focus in high risk lymphoma. He has presented at major national meetings, won the American Society of Hematology’s Abstract Achievement Award in 2013, and has several publications including a recent article in Blood on double hit lymphomas. Dr. Gandhi is currently an Associate Member of both the American Society of Hematology and the American Society of Clinical Oncology.

In his spare time, Dr. Gandhi enjoys traveling with his wife, reading and writing, and spending time with family and friends.


Patient Testimonials

Physician Video:


Practice Blog

February 14, 2024

Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes

Read More
October 11, 2021

Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

Read More

Physician Publications

December 6, 2020

Safety and Antitumor Activity Study Evaluating Loncastuximab Tesirine and Rituximab Versus Immunochemotherapy in Diffuse Large B-Cell Lymphoma

Read More
December 5, 2020

NHL Patients and Nurses in the US Prefer Subcutaneous Rituximab Injection Versus Intravenous Rituximab Infusion: A Real-World Study

Read More
February 15, 2016

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.

Read More

More Publications by Mitul Gandhi, MD

May 1, 2014

Pancreatitis in patients treated with Brentuximab Vedotin: A previously unrecognized serious adverse

Read More
April 22, 2014

Predicting benefit from imatinib. Are we close? Leukemia and Lymphoma.

Read More
February 13, 2014

Targeted treatment of head and neck squamous cell carcinoma: potential of lapatinib.

Read More
November 15, 2013

Impact of Induction Regimen and Consolidative Stem Cell Transplantation in Double Hit Lymphoma (DHL)

Read More
January 7, 2013

Association of implantable defibrillator therapy risk with body mass index in systolic heart failure

Read More
January 1, 2013

Brentuximab Vedotin in Patients with Relapsed HIV-Related Lymphoma

Read More